Belfast: City council set to bid to purchase Assembly Rooms
'Full-circle moment'
A council spokesperson told BBC News NI: "Elected members agreed that the council should purchase the Assembly Rooms and associated lands. The committee gave authority for the council to make an offer to the landowner."These lands include part of the North Street car park, 5-9 North Street and Braddell's Building, a grade B1 listed building at 11 North Street."This decision remains subject to ratification at the next full meeting of council."Alliance councillor Emmet McDonough-Brown welcomed the move and said it would be a "full-circle moment" if the Assembly Rooms returned to public use.It has yet to be decided exactly how the Assembly Rooms would be utilised by the council.
'Huge moment'
The historic building belongs to Castlebrooke Investments, which is behind the delayed Tribeca development in Belfast city centre.Built in 1769, the Assembly Rooms are at the corner of North Street and Waring Street. In spite of the building's historical and cultural significance, it has fallen out of use in the past two decades.The Assembly Rooms have been placed on a list of global 'at risk' heritage sites by the World Monuments Fund.The Green Party described news of the council's potential purchase as a "huge moment" for Belfast.A spokesperson said: "We are delighted at being able to secure the future of this historic building and are excited for what the next chapter of this culturally significant site will hold."The next full meeting of the city council is due to take place on 1 September, when a final decision is expected to be taken.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Edinburgh Reporter
an hour ago
- Edinburgh Reporter
Verida AFI Reviews: A Real Strategy for Recovering Stolen Cryptocurrency
In the world of digital finance, promising technologies often come with high risks. Attacks on crypto wallets are becoming increasingly sophisticated—seed phrase hacks, phishing sites, malicious extensions, trojans… the threats are relentless. Fortunately, so are those who stand against them. UK-based law firm Verida AFI has developed an effective system to help recover stolen digital assets—even in seemingly hopeless cases. Positive reviews of Verida AFI show this service is in high demand. Success Stories That Speak Volumes Every successful case brings Verida AFI not only gratitude, but also new proof that recovering stolen cryptocurrency is not a pipe dream, but real-world practice. Find reviews on: HackMD Medium GitHub Clients highlight: The firm's effectiveness where local police wouldn't help Clear, jargon-free communication Fair terms—no upfront fees, only payout based on recovered funds 'I thought everything was lost. But after two months, part of the funds were back. A miracle? No, just Verida AFI doing their job.' Why Losing Crypto Isn't a Death Sentence The idea of crypto anonymity is a myth criminals love to exploit. But blockchain records every transaction permanently. If you know how to follow the trail, it's all there. Verida AFI uses this to turn the blockchain into a solid evidentiary trail—tracking funds through aliases, transit wallets, exchanges, and cash-out points. From Digital Trail to Real Funds Recovery begins with analyzing transaction flows using OSINT and blockchain analytics to identify: Wallet addresses tied to scammers Exchanges used for withdrawals IP addresses, devices, services involved Potential geographic locations Once the trail is found, Verida AFI takes legal action—filing freeze requests with exchanges, working with regulators, preparing claims, and, if needed, contacting law enforcement, Interpol, or international courts. Photo by Towfiqu barbhuiya: Merging Tech with Legal Expertise Verida AFI's strategy includes: Global coordination with exchanges and financial bodies Criminal claims and lawsuits Asset-freeze petitions Linking wallet addresses to criminals through documented analysis Helping restore wallet access, even if keys are compromised All actions follow legal frameworks, supported by high-tech blockchain analysis used in cybercrime investigations worldwide. Fee Structure That Protects You Their fee is based on success: 5–7% of recovered assets, paid only upon result. No upfront payments. This low-risk model makes their services accessible to those already affected. Who They Serve Clients include more than just crypto traders—they help NFT owners, DeFi participants, users deceived by 'trusted' investment platforms, and entrepreneurs holding funds in stablecoins. Regardless of the case, Verida AFI provides a tailored strategy, rooted in persistence and expertise. Your wallet was hacked and assets transferred elsewhere You fell victim to phishing or insider threats Malware or unauthorized access compromised your keys Or you simply want to understand where your crypto went and whether recovery is possible Verida AFI not only helps recover what was lost—they also teach you how to protect your assets in the future. In crypto, the most valuable asset is awareness. Conclusion As cybercriminal methods evolve, so do countermeasures. Don't stay silent or write off lost crypto as gone forever. A timely approach with Verida AFI could be the key to retrieval. In the digital world, nothing is truly lost—if you know where and how to look. Like this: Like Related
Telegraph
an hour ago
- Telegraph
Trump threatens tariffs on medicines within weeks
Donald Trump has threatened new tariffs on medicines within weeks as he steps up demands for drugmakers to move factories to the US. The president said he would impose tariffs on pharmaceutical imports 'probably at the end of the month', adding: 'We're going to start off with a low tariff and give the pharmaceutical companies a year or so to build, and then we're going to make it a very high tariff.' It follows warnings earlier this month that tariffs could be as high as 200pc for medicines imported into the US. On Tuesday evening, the president suggested the new pharma tariffs could come alongside the 'reciprocal' rates which are expected to be implemented on Aug 1. Shares in European drugmakers including AstraZeneca, GSK, Novartis and Novo Nordisk dropped following Mr Trump's latest comments. Already, drug makers have been racing to bolster their presence in the US, with companies including GSK and Roche ramping up investment in US factories. Last month, reports suggested that AstraZeneca chief Sir Pascal Soriot had privately spoken of his desire to quit Britain for the US, shifting the company's listing away from London. It comes amid growing concern that the UK could be hit by new drug levies, despite agreeing a trade deal with Mr Trump. The UK is not as exposed as Ireland, which exports €58bn (£50bn) in pharma and chemicals to the US every year and has warned tariffs could slash this in half. However, the pharma sector still accounts for a large portion of the UK's exports to the US, with companies sending £8.8bn of pharmaceutical products to the US. Under the US-UK deal, ministers had pledged to make the UK more welcoming to US pharmaceutical companies, saying they would 'endeavour to improve the overall environment for pharmaceutical companies operating in the UK'. However, drugmakers warned that the UK was failing to deliver on that promise. They said the Government's long-awaited life sciences strategy – which was published on Wednesday – fell short on making Britain a better place to operate. The Government announced ambitions to reduce delays for clinical trials and said such plans would help make the UK the third-most important life sciences economy behind only the US and China by 2035. However, drug chiefs criticised the plans amid an ongoing row over NHS drugs charges. The Government has so far failed to reach an agreement with industry over how much the NHS is able to claw back in rebates on drugs. Johan Kahlström, managing director for healthcare company Novartis UK & Ireland, said he was 'deeply concerned and disappointed that, despite extensive engagement, the Government's new life sciences sector plan fails to address core industry concerns around the UK's investment environment'. Richard Torbett, from The Association of the British Pharmaceutical Industry, said: 'The UK must address the core issue holding back the life sciences sector, the long-term disinvestment in innovative medicines that is increasingly preventing NHS patients from accessing medications that are available in other countries. 'Without change, the UK will continue the slow slide down international league tables for research, investment, and the availability of new medicines.'
BBC News
2 hours ago
- BBC News
Exmouth homes approved amid sewage capacity concerns
Initial plans for a housing development in Devon have been approved by council planners despite concerns being raise about sewage network scheme would see 75 homes built in Exmouth, on land to the north east of King's Garden and Leisure Centre on Hulham councillors raised concerns about the ability of the sewage network to cope with the number of homes despite reassurances from South West Water (SWW).East Devon District Council planning committee approved the outline scheme at a meeting on Tuesday but included a condition that sewage capacity was proven before homes were occupied. SWW told the committee it had conducted a thorough assessment of the sewage network, according to the Local Democracy Reporting Geoff Jung said he was concerned after the company said the system "should" be able to cope with the development. "I'm worried because they have only looked at the first 260m (about 850ft) of pipes from the development, yet there are another three miles (4.8km) of network," he said. 'Investing millions' Councillor MIke Howe said there was "no faith" in SWW."With all the facts we know about Exmouth and sewage overflows into the sea in particular, that have been increasing year over year, how can we stand with the SWW response that putting more sewage into a system won't increase overflows?" he asked. Ed Freeman, the assistant director for planning at the council, said he could "understand member concerns and lack of trust in SWW".However, he said: "We don't have contradictory evidence to their evidence, and the company is investing millions of pounds in the town. "We have also been conducting a water cycle study and it shows there is some capacity at the Maer Lane treatment works, so we don't have reason to question SWW."The committee voted in favour to approve the scheme, but attached a condition to include proof to be presented to the council that drainage is developer will now have to submit a more detailed application, which will include aspects like the exact number of homes, their design and layout on the site.
